Literature DB >> 18773265

Effects of photodynamic therapy on the choriocapillaris and retinal pigment epithelium in the irradiated area.

Nadia Artha Dewi1, Mitsuko Yuzawa2, Kasumi Tochigi1, Akiyuki Kawamura1, Ryusaburo Mori1.   

Abstract

PURPOSE: To evaluate the effect of photodynamic therapy (PDT) on the choriocapillaris and retinal pigment epithelium (RPE) in the irradiated area surrounding choroidal neovascularization (CNV) during 12 months of follow-up.
METHODS: We reviewed the medical records, and indocyanine green angiography (IA), fluorescein angiography (FA), and fundus photographic findings of 72 eyes (72 patients) with CNV associated with age-related macular degeneration (AMD) or polypoidal choroidal vasculopathy (PCV). Patients were divided into three groups based on the number of PDT sessions. Twelve months after PDT, we evaluated the relationship between the number of sessions and both the presence of hypofluorescence in the late phase of IA and window defects observed on FA in the irradiated areas.
RESULTS: Twenty-three patients had one PDT session (group I), 25 had two (group II), and 24 had three or four (group III). IA revealed hypofluorescence indicating a choriocapillaris filling defect within the irradiated area in 11 eyes (48%) in group I, 18 (72%) in group II, and 22 (91%) in group III. The correlation between the number of PDT sessions and hypofluorescence in the irradiated areas was significant. FA showed window defects surrounding CNV in 26%, 52%, and 71% of eyes from groups I, II, and III, respectively. Subretinal hemorrhages had been present in 23 eyes (32%) and exudation in 13 (18%) prior to PDT. Areas without hemorrhages or exudation prior to PDT had a normal appearance within the irradiated area in all 72 eyes.
CONCLUSIONS: Although the RPE in the irradiated area was preserved, 12 months after PDT, mild choriocapillaris occlusion was detected in the irradiated area in eyes that had undergone multiple PDT sessions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18773265     DOI: 10.1007/s10384-008-0551-9

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  17 in total

1.  Histopathological changes following photodynamic therapy in human eyes.

Authors:  Ursula Schmidt-Erfurth; Horst Laqua; Ursula Schlötzer-Schrehard; Arne Viestenz; Gottfried O H Naumann
Journal:  Arch Ophthalmol       Date:  2002-06

2.  RPE atrophy following photodynamic therapy in type 2A idiopathic parafoveal telangiectasis.

Authors:  Mahesh P Shanmugam; Manisha Agarwal
Journal:  Indian J Ophthalmol       Date:  2005-03       Impact factor: 1.848

3.  BDNF reduces the retinal toxicity of verteporfin photodynamic therapy.

Authors:  Daniel M Paskowitz; George Nune; Douglas Yasumura; Haidong Yang; Robert B Bhisitkul; Shivani Sharma; Michael T Matthes; Marco A Zarbin; Matthew M Lavail; Jacque L Duncan
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-11       Impact factor: 4.799

4.  Role of photodynamic therapy in polypoidal choroidal vasculopathy.

Authors:  Nazimul Hussain; Anjli Hussain; Sundaram Natarajan
Journal:  Indian J Ophthalmol       Date:  2005-06       Impact factor: 1.848

5.  Photodynamic effects on choroidal neovascularization and physiological choroid.

Authors:  Ursula Schmidt-Erfurth; Stephan Michels; Irene Barbazetto; Horst Laqua
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-03       Impact factor: 4.799

6.  Effects of photodynamic therapy using verteporfin on experimental choroidal neovascularization and normal retina and choroid up to 7 weeks after treatment.

Authors:  D Husain; M Kramer; A G Kenny; N Michaud; T J Flotte; E S Gragoudas; J W Miller
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-09       Impact factor: 4.799

7.  Sequence of early vascular events after photodynamic therapy.

Authors:  Stephan Michels; Ursula Schmidt-Erfurth
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-05       Impact factor: 4.799

8.  Verteporfin therapy for myopic choroidal neovascularisation in Indian eyes (one year results).

Authors:  Nazimul Hussain; Taraprasad Das; Urvish Vashist; Kallukuri Sumashri
Journal:  Indian J Ophthalmol       Date:  2004-09       Impact factor: 1.848

9.  Changes in confocal indocyanine green angiography through two years after photodynamic therapy with verteporfin.

Authors:  Ursula M Schmidt-Erfurth; Stephan Michels
Journal:  Ophthalmology       Date:  2003-07       Impact factor: 12.079

10.  Photodynamic therapy with verteporfin for polypoidal choroidal vasculopathy of the macula.

Authors:  Sung Chul Lee; Youl Seok Seong; Sung Soo Kim; Hyung Jun Koh; Oh Woong Kwon
Journal:  Ophthalmologica       Date:  2004 May-Jun       Impact factor: 3.250

View more
  7 in total

1.  Three-year follow-up results of photodynamic therapy for polypoidal choroidal vasculopathy.

Authors:  Eriko Akaza; Mitsuko Yuzawa; Ryusaburo Mori
Journal:  Jpn J Ophthalmol       Date:  2011-02-18       Impact factor: 2.447

2.  Association of Choroidal Neovascularization and Central Serous Chorioretinopathy With Optical Coherence Tomography Angiography.

Authors:  Marco Antonio Bonini Filho; Talisa E de Carlo; Daniela Ferrara; Mehreen Adhi; Caroline R Baumal; Andre J Witkin; Elias Reichel; Jay S Duker; Nadia K Waheed
Journal:  JAMA Ophthalmol       Date:  2015-08       Impact factor: 7.389

3.  Combined therapy (intravitreal bevacizumab plus verteporfin photodynamic therapy) versus intravitreal bevacizumab monotherapy for choroidal neovascularization due to age-related macular degeneration: a 1-year follow-up study.

Authors:  Sandro Saviano; Pia Easter Leon; Alessandro Mangogna; Daniele Tognetto
Journal:  Digit J Ophthalmol       Date:  2016-06-30

4.  Topically applied hypericin exhibits skin penetrability on nude mice.

Authors:  Zhuo-Heng Li; Yuan-Yuan Li; Min Hou; Tao Yang; Lai-Chun Lu; Xiao-Yu Xu
Journal:  Lasers Med Sci       Date:  2018-06-13       Impact factor: 3.161

5.  Individualized ranibizumab therapy strategies in year 3 after as-needed treatment for polypoidal choroidal vasculopathy.

Authors:  Taiichi Hikichi
Journal:  BMC Ophthalmol       Date:  2015-04-10       Impact factor: 2.209

6.  Impact of methylenetetrahydrofolate reductase C677T polymorphism on the efficacy of photodynamic therapy in patients with neovascular age-related macular degeneration.

Authors:  Francesco Parmeggiani; Carla Enrica Gallenga; Ciro Costagliola; Francesco Semeraro; Mario R Romano; Roberto Dell'Omo; Andrea Russo; Katia De Nadai; Donato Gemmati; Sergio D'Angelo; Elena Bolletta; Francesco Saverio Sorrentino
Journal:  Sci Rep       Date:  2019-02-22       Impact factor: 4.379

7.  Effect of Factor XIII-A G185T Polymorphism on Visual Prognosis after Photodynamic Therapy for Neovascular Macular Degeneration.

Authors:  Francesco Parmeggiani; Ciro Costagliola; Francesco Semeraro; Mario R Romano; Michele Rinaldi; Carla Enrica Gallenga; Maria Luisa Serino; Carlo Incorvaia; Sergio D'Angelo; Katia De Nadai; Roberto Dell'Omo; Andrea Russo; Donato Gemmati; Paolo Perri
Journal:  Int J Mol Sci       Date:  2015-08-20       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.